West Pharmaceutical Services, the Exton based leader in innovative solutions for injectable drug technology has appointed Eric Resnick as Vice President and Chief Technology Officer. Resnick will succeed John Paproski, who plans to retire on April 1 after over 36 years of exemplary service.

In his new position, Resnick will be heading the company’s Innovation and Technology Team, established to create the next generation of products, starting with innovation in the commercial stage and carrying over into the packaging, containment and product delivery areas.  

“Over the past 15 years, Eric Resnick has been a pivotal leader within West. His work to bring the SmartDose electronic wearable injector from concept to commercialization is among many of his accomplishments,” said Eric M. Green, President and CEO of West. “Eric is a well-respected and proven leader at West who will bring valuable skills and experience to the West leadership team.”